Biotech · Public company · Lighthouse Point, FL, US
ZyVersa Therapeutics, Inc.
Ticker ZVSA · SEC CIK 0001859007
Track this companyFree. Adds ZyVersa Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- 2HPβCDPhase 2 · Diabetic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney DiseasePHASE2 · WITHDRAWN · started Jun 11, 2025ClinicalTrials.gov NCT06489340 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Jul 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 3, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 19, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 19, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 15, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 18, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2025 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Aug 1, 2025 · fetched Nov 12, 2026